Rightslink® by Copyright Clearance Center

FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study

Author:

Nicola Personeni,Lorenza Rimassa,Claudio Verusio,Sandro Barni,Luca Rubino,Silvia Bozzarelli,Eugenio Villa,Carlo Carnaghi,Maria Chiara Tronconi,Chiara Gerardi,Francesca Galli,Irene Floriani,Annarita Destro,Carlotta Raschioni,Roberto Labianca et al.

Publication:

Clinical Colorectal Cancer

Publisher:

Elsevier

Date:

September 2015

Please select your organization and/or account

Organization

Account

Please select your account from the above dropdown list. These accounts represent the offices, campuses, and other sites where your organization operates. Your account selection should match where you typically have an office or workspace. Even when you are traveling or temporarily working elsewhere, you should select the account that represents where you customarily work.

Cancel OK

Welcome to RightsLink

Elsevier has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing this content.

I would like to...This drop down menu contains the options the publisher has agreed to permit for reuse of their copyrighted material. The publisher offers these types of use either directly through RightsLink or after approval by the publisher. Please reference the terms and conditions offered during the order process for a complete understanding of the use you select. Need more info?